Diabetes: Bariatric surgery bests medical treatment in improving kidney disease
Delhi: Gastric bypass is more effective than the best medical treatment (BMT) in improving kidney disease in people with obesity and type 2 diabetes (T2D), a recent study in the journal JAMA Surgery. It found roux-en-Y gastric bypass (RYGB) to be a safe and more effective means of achieving remission of early-stage CKD and albuminuria than BMT treatment in patients with type 2 diabetes, obesity, and microalbuminuria.
The study is significant as in T2D patients early-stage chronic kidney disease (CKD) characterized by microalbuminuria is associated with future cardiovascular events, progression toward end-stage renal disease, and early mortality.
Ricardo Vitor Cohen, The Center for Obesity and Diabetes, Oswaldo Cruz German Hospital, São Paulo, Brazil, and colleagues conducted the study to compare the albuminuria-lowering effects of Roux-en-Y gastric bypass (RYGB) surgery vs best medical treatment in patients with early-stage CKD, type 2 diabetes, and obesity.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.